Published in Biomaterials on February 04, 2013
PEGylation as a strategy for improving nanoparticle-based drug and gene delivery. Adv Drug Deliv Rev (2015) 1.08
A biophysical basis for mucus solids concentration as a candidate biomarker for airways disease. PLoS One (2014) 1.03
Probing biological nanotopology via diffusion of weakly constrained plasmonic nanorods with optical coherence tomography. Proc Natl Acad Sci U S A (2014) 0.89
Overcoming the cystic fibrosis sputum barrier to leading adeno-associated virus gene therapy vectors. Mol Ther (2014) 0.88
Highly compacted biodegradable DNA nanoparticles capable of overcoming the mucus barrier for inhaled lung gene therapy. Proc Natl Acad Sci U S A (2015) 0.88
Ex vivo characterization of particle transport in mucus secretions coating freshly excised mucosal tissues. Mol Pharm (2013) 0.86
Particle tracking in drug and gene delivery research: State-of-the-art applications and methods. Adv Drug Deliv Rev (2015) 0.86
Highly PEGylated DNA Nanoparticles Provide Uniform and Widespread Gene Transfer in the Brain. Adv Healthc Mater (2015) 0.85
Topical Ocular Drug Delivery to the Back of the Eye by Mucus-Penetrating Particles. Transl Vis Sci Technol (2015) 0.80
The Mucus Barrier to Inhaled Gene Therapy. Mol Ther (2016) 0.79
Nanoparticle filtering in charged hydrogels: Effects of particle size, charge asymmetry and salt concentration. Eur Phys J E Soft Matter (2016) 0.78
Polymeric nanoparticles in development for treatment of pulmonary infectious diseases. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2016) 0.78
Minimizing biases associated with tracking analysis of submicron particles in heterogeneous biological fluids. J Control Release (2015) 0.78
Barriers to inhaled gene therapy of obstructive lung diseases: A review. J Control Release (2016) 0.77
Microstructural alterations of sputum in cystic fibrosis lung disease. JCI Insight (2016) 0.76
Biodegradable DNA Nanoparticles that Provide Widespread Gene Delivery in the Brain. Small (2015) 0.76
Advanced Therapeutic Strategies for Chronic Lung Disease Using Nanoparticle-Based Drug Delivery. J Clin Med (2016) 0.76
Nanoparticles coated with high molecular weight PEG penetrate mucus and provide uniform vaginal and colorectal distribution in vivo. Nanomedicine (Lond) (2016) 0.75
Nanoparticles that do not adhere to mucus provide uniform and long-lasting drug delivery to airways following inhalation. Sci Adv (2017) 0.75
Pretreatment of human cervicovaginal mucus with pluronic F127 enhances nanoparticle penetration without compromising mucus barrier properties to herpes simplex virus. Biomacromolecules (2014) 0.75
A Model for the Transient Subdiffusive Behavior of Particles in Mucus. Biophys J (2017) 0.75
The biophysical properties of Basal lamina gels depend on the biochemical composition of the gel. PLoS One (2015) 0.75
Particle-Tracking Microrheology Using Micro-Optical Coherence Tomography. Biophys J (2016) 0.75
The movement and deposition of PM2.5 in the upper respiratory tract for the patients with heart failure: an elementary CFD study. Biomed Eng Online (2016) 0.75
Pulsed ultrasound expands the extracellular and perivascular spaces of the brain. Brain Res (2016) 0.75
Aerosol Delivery of siRNA to the Lungs. Part 1: Rationale for Gene Delivery Systems. Kona (2015) 0.75
Disentangling Random Motion and Flow in a Complex Medium. Biophys J (2016) 0.75
Enhancement of lung gene delivery after aerosol: a new strategy using non-viral complexes with antibacterial properties. Biosci Rep (2017) 0.75
Single-particle tracking: applications to membrane dynamics. Annu Rev Biophys Biomol Struct (1997) 12.64
Optical measurements of frequency-dependent linear viscoelastic moduli of complex fluids. Phys Rev Lett (1995) 4.50
Airway mucus function and dysfunction. N Engl J Med (2010) 4.41
Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus. Proc Natl Acad Sci U S A (2007) 3.94
Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues. Adv Drug Deliv Rev (2008) 3.41
Nanoparticle PEGylation for imaging and therapy. Nanomedicine (Lond) (2011) 3.33
A periciliary brush promotes the lung health by separating the mucus layer from airway epithelia. Science (2012) 2.98
Barrier properties of mucus. Adv Drug Deliv Rev (2008) 2.84
Antibody diffusion in human cervical mucus. Biophys J (1994) 2.82
The relative roles of passive surface forces and active ion transport in the modulation of airway surface liquid volume and composition. J Gen Physiol (2001) 2.28
Real-time multiple-particle tracking: applications to drug and gene delivery. Adv Drug Deliv Rev (2005) 2.21
Nanoparticles reveal that human cervicovaginal mucus is riddled with pores larger than viruses. Proc Natl Acad Sci U S A (2009) 2.13
Colloid surface chemistry critically affects multiple particle tracking measurements of biomaterials. Biophys J (2004) 2.02
Anomalous diffusion probes microstructure dynamics of entangled F-actin networks. Phys Rev Lett (2004) 1.96
Relating microstructure to rheology of a bundled and cross-linked F-actin network in vitro. Proc Natl Acad Sci U S A (2004) 1.91
A dense poly(ethylene glycol) coating improves penetration of large polymeric nanoparticles within brain tissue. Sci Transl Med (2012) 1.85
Three-dimensional fluorescence recovery after photobleaching with the confocal scanning laser microscope. Biophys J (2003) 1.83
STUDIES ON PULMONARY SECRETIONS. I. THE OVER-ALL CHEMICAL COMPOSITION OF PULMONARY SECRETIONS FROM PATIENTS WITH CYSTIC FIBROSIS, BRONCHIECTASIS, AND LARYNGECTOMY. Am Rev Respir Dis (1963) 1.81
Mucus-penetrating nanoparticles for vaginal drug delivery protect against herpes simplex virus. Sci Transl Med (2012) 1.68
The penetration of fresh undiluted sputum expectorated by cystic fibrosis patients by non-adhesive polymer nanoparticles. Biomaterials (2009) 1.54
Comparison of samples collected by sputum induction and bronchoscopy from asthmatic and healthy subjects. Am J Respir Crit Care Med (1995) 1.52
Nanoparticle conjugation of antigen enhances cytotoxic T-cell responses in pulmonary vaccination. Proc Natl Acad Sci U S A (2011) 1.39
Altering mucus rheology to "solidify" human mucus at the nanoscale. PLoS One (2009) 1.37
Cystic fibrosis sputum: a barrier to the transport of nanospheres. Am J Respir Crit Care Med (2000) 1.35
The physical properties of biogels and their permeability for macromolecular drugs and colloidal drug carriers. J Pharm Sci (2000) 1.20
Basic rheology for biologists. Methods Cell Biol (2007) 1.15
Ex vivo sputum analysis reveals impairment of protease-dependent mucus degradation by plasma proteins in acute asthma. Am J Respir Crit Care Med (2009) 1.11
Fluorometric assay of O-linked glycoproteins by reaction with 2-cyanoacetamide. Anal Biochem (1987) 1.11
Sputum rheology changes in cystic fibrosis lung disease following two different types of physiotherapy: flutter vs autogenic drainage. Chest (1998) 1.09
Inhibition of lung tumor growth by complex pulmonary delivery of drugs with oligonucleotides as suppressors of cellular resistance. Proc Natl Acad Sci U S A (2010) 1.08
Mobility of Nonsticky Nanoparticles in Polymer Liquids. Macromolecules (2011) 1.04
Drug carrier nanoparticles that penetrate human chronic rhinosinusitis mucus. Biomaterials (2011) 1.04
Collection and analysis of respiratory mucus from subjects without lung disease. Am Rev Respir Dis (1990) 1.04
Rapid transport of muco-inert nanoparticles in cystic fibrosis sputum treated with N-acetyl cysteine. Nanomedicine (Lond) (2011) 1.01
N-acetylcysteine enhances cystic fibrosis sputum penetration and airway gene transfer by highly compacted DNA nanoparticles. Mol Ther (2011) 0.98
Nanoparticle conjugation and pulmonary delivery enhance the protective efficacy of Ag85B and CpG against tuberculosis. Vaccine (2011) 0.98
Conductive airway surfactant: surface-tension function, biochemical composition, and possible alveolar origin. Am J Respir Cell Mol Biol (1997) 0.97
Airway surfactant, a primary defense barrier: mechanical and immunological aspects. J Aerosol Med (1996) 0.96
Elastic contributions dominate the viscoelastic properties of sputum from cystic fibrosis patients. Biophys Chem (2004) 0.84
General anesthesia does not alter the viscoelastic or transport properties of human respiratory mucus. Chest (1990) 0.83
Biochemistry. Walking on solid ground. Science (2012) 0.82
Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus. Proc Natl Acad Sci U S A (2007) 3.94
Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues. Adv Drug Deliv Rev (2008) 3.41
Micro- and macrorheology of mucus. Adv Drug Deliv Rev (2009) 2.54
Efficient active transport of gene nanocarriers to the cell nucleus. Proc Natl Acad Sci U S A (2003) 2.52
Human immunodeficiency virus type 1 is trapped by acidic but not by neutralized human cervicovaginal mucus. J Virol (2009) 2.49
Addressing the PEG mucoadhesivity paradox to engineer nanoparticles that "slip" through the human mucus barrier. Angew Chem Int Ed Engl (2008) 2.38
Real-time multiple-particle tracking: applications to drug and gene delivery. Adv Drug Deliv Rev (2005) 2.21
Nanoparticles reveal that human cervicovaginal mucus is riddled with pores larger than viruses. Proc Natl Acad Sci U S A (2009) 2.13
Enhanced viscoelasticity of human cystic fibrotic sputum correlates with increasing microheterogeneity in particle transport. J Biol Chem (2003) 2.01
Biodegradable polymer nanoparticles that rapidly penetrate the human mucus barrier. Proc Natl Acad Sci U S A (2009) 1.86
A dense poly(ethylene glycol) coating improves penetration of large polymeric nanoparticles within brain tissue. Sci Transl Med (2012) 1.85
A functional anatomic defect of the cystic fibrosis airway. Am J Respir Crit Care Med (2014) 1.85
Mucus-penetrating nanoparticles for vaginal drug delivery protect against herpes simplex virus. Sci Transl Med (2012) 1.68
Hyperglycemia independently increases the risk of perioperative stroke, myocardial infarction, and death after carotid endarterectomy. Neurosurgery (2006) 1.67
Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers. Adv Drug Deliv Rev (2011) 1.65
Effect of antibiotic-impregnated shunt catheters in decreasing the incidence of shunt infection in the treatment of hydrocephalus. J Neurosurg (2005) 1.64
3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors reduce the risk of perioperative stroke and mortality after carotid endarterectomy. J Vasc Surg (2005) 1.63
Traumatic pericallosal artery aneurysm: a rare complication of transcallosal surgery. Case report. J Neurosurg (2007) 1.61
Privileged delivery of polymer nanoparticles to the perinuclear region of live cells via a non-clathrin, non-degradative pathway. Biomaterials (2007) 1.59
The penetration of fresh undiluted sputum expectorated by cystic fibrosis patients by non-adhesive polymer nanoparticles. Biomaterials (2009) 1.54
MRI-detectable pH nanosensors incorporated into hydrogels for in vivo sensing of transplanted-cell viability. Nat Mater (2013) 1.53
Leukocyte-inspired biodegradable particles that selectively and avidly adhere to inflamed endothelium in vitro and in vivo. Proc Natl Acad Sci U S A (2003) 1.48
Independent predictors of morbidity after image-guided stereotactic brain biopsy: a risk assessment of 270 cases. J Neurosurg (2005) 1.40
Altering mucus rheology to "solidify" human mucus at the nanoscale. PLoS One (2009) 1.37
Functional genomic screening identifies dual leucine zipper kinase as a key mediator of retinal ganglion cell death. Proc Natl Acad Sci U S A (2013) 1.36
Quantifying the intracellular transport of viral and nonviral gene vectors in primary neurons. Exp Biol Med (Maywood) (2007) 1.31
New polymeric carriers for controlled drug delivery following inhalation or injection. Biomaterials (2002) 1.27
Biodegradable nanoparticles composed entirely of safe materials that rapidly penetrate human mucus. Angew Chem Int Ed Engl (2011) 1.23
PEGylation of nanoparticles improves their cytoplasmic transport. Int J Nanomedicine (2007) 1.20
Transport of polymeric nanoparticle gene carriers in gastric mucus. Biotechnol Prog (2004) 1.20
Real-time intracellular transport of gene nanocarriers studied by multiple particle tracking. Biotechnol Prog (2004) 1.19
Characterization of the intracellular dynamics of a non-degradative pathway accessed by polymer nanoparticles. J Control Release (2007) 1.07
Predictors of ambulatory function after decompressive surgery for metastatic epidural spinal cord compression. Neurosurgery (2008) 1.06
Mucus penetrating nanoparticles: biophysical tool and method of drug and gene delivery. Adv Mater (2012) 1.05
Drug carrier nanoparticles that penetrate human chronic rhinosinusitis mucus. Biomaterials (2011) 1.04
Novel approaches to vaginal delivery and safety of microbicides: biopharmaceuticals, nanoparticles, and vaccines. Antiviral Res (2010) 1.04
Highly compacted DNA nanoparticles with low MW PEG coatings: in vitro, ex vivo and in vivo evaluation. J Control Release (2011) 1.03
Poly(ether-anhydride) dry powder aerosols for sustained drug delivery in the lungs. J Control Release (2004) 1.02
Rapid transport of muco-inert nanoparticles in cystic fibrosis sputum treated with N-acetyl cysteine. Nanomedicine (Lond) (2011) 1.01
Gene delivery to differentiated neurotypic cells with RGD and HIV Tat peptide functionalized polymeric nanoparticles. Biomaterials (2006) 1.00
Enhanced adhesion of ligand-conjugated biodegradable particles to colitic venules. FASEB J (2005) 1.00
Neurological outcome after resection of intramedullary spinal cord tumors in children. Childs Nerv Syst (2007) 1.00
Common gene therapy viral vectors do not efficiently penetrate sputum from cystic fibrosis patients. PLoS One (2011) 0.99
Mucoadhesive nanoparticles may disrupt the protective human mucus barrier by altering its microstructure. PLoS One (2011) 0.99
N-acetylcysteine enhances cystic fibrosis sputum penetration and airway gene transfer by highly compacted DNA nanoparticles. Mol Ther (2011) 0.98
Enhanced efficacy of local etoposide delivery by poly(ether-anhydride) particles against small cell lung cancer in vivo. Biomaterials (2009) 0.96
Persistent perioperative hyperglycemia as an independent predictor of poor outcome after aneurysmal subarachnoid hemorrhage. J Neurosurg (2007) 0.96
Vaginal delivery of paclitaxel via nanoparticles with non-mucoadhesive surfaces suppresses cervical tumor growth. Adv Healthc Mater (2013) 0.95
Risk of cerebral vasopasm after subarachnoid hemorrhage reduced by statin therapy: A multivariate analysis of an institutional experience. J Neurosurg (2006) 0.95
Brain-penetrating nanoparticles improve paclitaxel efficacy in malignant glioma following local administration. ACS Nano (2014) 0.93
Scalable method to produce biodegradable nanoparticles that rapidly penetrate human mucus. J Control Release (2013) 0.93
Large porous particle impingement on lung epithelial cell monolayers--toward improved particle characterization in the lung. Pharm Res (2003) 0.92
Nanoparticle diffusion in, and microrheology of, the bovine vitreous ex vivo. J Control Release (2013) 0.92
Sustained delivery of a HIF-1 antagonist for ocular neovascularization. J Control Release (2013) 0.92
Adjustable vs set-pressure valves decrease the risk of proximal shunt obstruction in the treatment of pediatric hydrocephalus. Childs Nerv Syst (2006) 0.91
Enhancement of airway gene transfer by DNA nanoparticles using a pH-responsive block copolymer of polyethylene glycol and poly-L-lysine. Biomaterials (2011) 0.91
Persistent outpatient hyperglycemia is independently associated with survival, recurrence and malignant degeneration following surgery for hemispheric low grade gliomas. Neurol Res (2009) 0.91
Real-time multiple particle tracking of gene nanocarriers in complex biological environments. Methods Mol Biol (2008) 0.91
Non-degradative intracellular trafficking of highly compacted polymeric DNA nanoparticles. J Control Release (2011) 0.91
Use of single-site-functionalized PEG dendrons to prepare gene vectors that penetrate human mucus barriers. Angew Chem Int Ed Engl (2013) 0.90
A poly(ethylene glycol)-based surfactant for formulation of drug-loaded mucus penetrating particles. J Control Release (2011) 0.90
Factors contributing to the medical costs of cerebrospinal fluid shunt infection treatment in pediatric patients with standard shunt components compared with those in patients with antibiotic impregnated components. Neurosurg Focus (2007) 0.89
Markedly enhanced skeletal muscle transfection achieved by the ultrasound-targeted delivery of non-viral gene nanocarriers with microbubbles. J Control Release (2012) 0.88
Factors associated with cervical instability requiring fusion after cervical laminectomy for intradural tumor resection. J Neurosurg Spine (2008) 0.87
Influence of apical fluid volume on the development of functional intercellular junctions in the human epithelial cell line 16HBE14o-: implications for the use of this cell line as an in vitro model for bronchial drug absorption studies. Cell Tissue Res (2002) 0.87
Polymeric particles conjugated with a ligand to VCAM-1 exhibit selective, avid, and focal adhesion to sites of atherosclerosis. Biotechnol Bioeng (2008) 0.86
Ex vivo characterization of particle transport in mucus secretions coating freshly excised mucosal tissues. Mol Pharm (2013) 0.86
Biodegradable mucus-penetrating nanoparticles composed of diblock copolymers of polyethylene glycol and poly(lactic-co-glycolic acid). Drug Deliv Transl Res (2012) 0.86
Local immunotherapy with interleukin-2 delivered from biodegradable polymer microspheres combined with interstitial chemotherapy: a novel treatment for experimental malignant glioma. Neurosurgery (2003) 0.85
Biotargeted nanomedicines for cancer: six tenets before you begin. Nanomedicine (Lond) (2013) 0.85
Particulate matter in cigarette smoke increases ciliary axoneme beating through mechanical stimulation. J Aerosol Med Pulm Drug Deliv (2012) 0.83
Real-time gene delivery vector tracking in the endo-lysosomal pathway of live cells. Microsc Res Tech (2011) 0.83
Sites in the AAV5 capsid tolerant to deletions and tandem duplications. Arch Biochem Biophys (2010) 0.83
Transport of metal oxide nanoparticles and single-walled carbon nanotubes in human mucus. Nanotoxicology (2011) 0.82
The microstructure and bulk rheology of human cervicovaginal mucus are remarkably resistant to changes in pH. Biomacromolecules (2013) 0.82
Two-needle technique for the treatment of symptomatic Tarlov cysts. J Vasc Interv Radiol (2008) 0.81
Scleral permeability varies by mouse strain and is decreased by chronic experimental glaucoma. Invest Ophthalmol Vis Sci (2014) 0.80
From bench to bedside: successful translational nanomedicine: highlights of the Third Annual Meeting of the American Academy of Nanomedicine. Nanomedicine (2007) 0.80
Model development and numerical simulation of electric-stimulus-responsive hydrogels subject to an externally applied electric field. Biosens Bioelectron (2004) 0.80
Thoracic kyphotic deformity reduction with a distractible titanium cage via an entirely posterior approach. Neurosurgery (2007) 0.80
Hyperglycemia is independently associated with post-operative function loss in patients with primary eloquent glioblastoma. J Clin Neurosci (2012) 0.80
Modulating Vibrio cholerae quorum-sensing-controlled communication using autoinducer-loaded nanoparticles. Nano Lett (2015) 0.80
Preoperative statin and diuretic use influence the presentation of patients undergoing carotid endarterectomy: results of a large single-institution case-control study. J Vasc Surg (2007) 0.79
Development of delivery methods for carbohydrate-based drugs: controlled release of biologically-active short chain fatty acid-hexosamine analogs. Glycoconj J (2010) 0.79
Hyaluronan in cervical epithelia protects against infection-mediated preterm birth. J Clin Invest (2014) 0.79
Endoscopic endonasal approaches to the cavernous sinus. Int Forum Allergy Rhinol (2011) 0.78